The menopause supplement market is expected to be worth approximately USD 934.8 million in 2024, and witness a steep rise at a CAGR of 5.7% during the forecast period. The global menopause supplement market is anticipated to reach some USD 1,710.1 million in value in 2035.
As consumers increasingly embrace active aging, hormone-free products and customized women’s wellness, menopause supplement markets are soaring. Through this, the supplements will be best positioned to help alleviate physical, emotional and hormone-related symptoms of menopause hot flashes, mood swings, joint health, energy and bone density that women experience during this time.
Black cohosh, red clover, dong quai, soy isoflavones, magnesium, and vitamin D supplements fuel market demand. Format innovation i.e., in softgels, effervescent powders, gummies, and single packs of supplements is increasing availability and compliance among middle-aged consumers for non-hormonal or natural alternatives.
North America dominates the market with strong over-the-counter (OTC) uptake and strong penetration by women 45+ of functional well-being brands. Europe is still a first-class hotbed of botanical innovation, with Germany, France, and the Nordics enthusiastically adopting phytoestrogen-based formulations. Asia Pacific is meanwhile seeing growing demand as awareness of menopause transition builds, most strongly in Japan, South Korea, and urban India.
As telehealth platforms continue to grow, DTC menopause brands are taking advantage of AI-based symptom mapping and customized nutrition plans to spur subscription health channel revenues. Concurrently, global wellness businesses are collaborating with nutraceutical formulators to develop evidence-based SKUs for addressing clean label, vegan, and allergen-free requirements.
Attributes | Description |
---|---|
Estimated Global Menopause Supplement Industry Size (2025E) | USD 983.4 million |
Projected Global Menopause Supplement Industry Value (2035F) | USD 1,710.1 million |
Value-based CAGR (2025 to 2035) | 5.7% |
Market players like Estroven (i-Health), Amway, Bonafide Health, NOW Foods, and Nature's Way are completing their line-ups with clinically substantiated blends for relief of all except the most severe menopausal symptoms. Competition is also putting clinical substantiation and transparency into place to be able to compete favorably in a regulation-driven, highly competitive category.
Explore FMI!
Book a free demo
Following is comparative study of CAGR movement over half-year period in base year (2024) and current year (2025) of menopause supplement markets globally. The short-run market activity update helps to support brands as well as formulators to judge windows of performance. H1 is January-June; H2 is July-December.
Particular | Value CAGR |
---|---|
H1(2024 to 2034) | 5.3% |
H2(2024 to 2034) | 5.5% |
H1(2025 to 2035) | 5.6% |
H2(2025 to 2035) | 5.7% |
H1 2025 to 2035 growth of menopause supplement market would be 5.6% CAGR and then fractionally higher at 5.7% in H2. That is comparatively better than H1 2024 (5.3%) of 30 BPS and against H2 2024 (5.5%) of 20 BPS. All these are fueled by increasing e-commerce penetration, pack customization solutions, and increasing awareness for preventive care in emerging markets.
There is a competitive group of companies that are large revenue-wise, leadership-wise, and have deep market penetration in Tier 1. All of these companies have strong brand equity and high advertisement costs, invest in clinical evidence, and make products.
Amway is one such company, using its Nutrilite brand to distribute menopause-specific supplements around the world across markets through direct sales and web-based channels. Another commonly used one is Pfizer Inc., that sells hormone-free products under its subsidiary brands using huge research and quality pharmaceutical brand name.
They are market-dominant brands using clinically-backed ingredients such as soy isoflavones, vitamin mixes, and black cohosh, which address a big set of customers having high recall as well as trust scores.
Tier 2 consists of brands with revenues less than those of Tier 1 but established market presence. Estroven from i-Health, a division of DSM, is the market-leading brand in the category with premium menopause relief products with personalized hot flash, sleep, and mood products.
Its successful high concentration established market presence and broad distribution in North America create a solid niche following. One instance is NOW Foods, which offers several herbal menopause supplements and built a good reputation for quality, transparency, and value. These businesses care about effectiveness, clean-label promotion, and patient and consumer education and would prefer selling to health-oriented consumers seeking HRT-free, natural alternatives.
Tier 3 consists of new entrants and niche players emerging in the menopause supplement business. These actors prefer to promote products through direct-to-consumer marketing, influencer marketing, and social media. Bonafide Health, for example, is emerging as one to watch with clinically effective, non-hormonal supplements for menopausal women.
Ritual is one of those brands that has repositioned products to include women's health supplements with menopausal benefit profiles. These ones have lower reach through distribution compared to Tier 1 and Tier 2 brands but are increasing very rapidly since they are personalized, digital-first in orientation, and transparent.
Rise of Holistic and Natural Therapies
Shift:With women seeking alternatives to hormone replacement therapy, natural menopause supplements are all the rage. Over-the-counter herbal supplements like black cohosh, red clover and evening primrose oil have become the consumer remedy of choice for hot flashes, mood swings and insomnia - particularly in the USA, UK and Australia.
Strategic Response:Others, such as Estroven and Bonafide Health, were redesigned with clinically proven herbs and soy isoflavones. Holland & Barrett broadened the variety of herbal menopause relief, and New Chapter launched whole-food-based multivitamins specifically formulated for menopausal women, as increasingly health-savvy consumers take advantage.
Individualized and Stage-Based Solutions
Shift:Women choose tailor-made care in perimenopause, menopause, and post-menopause periods. Rather than off-the-shelf medicine, tailor-made schemes with changing hormones, lifestyle, and symptom severity are popular, particularly among women of the age group 40-60 years.
Strategic Response:Kindra and HUM Nutrition, for instance, have launched symptom-targeted SKUs-hot flashes, vaginal dryness, and mood formulas, among others. MenoLabs has also launched personalized supplement boxes and apps with hormone tracking. Personalization has boosted subscription retention rates and customer satisfaction across North America and Europe.
Subscription-Based and DTC Channel Growth
Shift:Active midlife consumers are embracing convenience and driving demand for direct-to-consumer (DTC) business and subscription delivery. The trend is most favored in urban locations in the USA, Canada, and the UK, where women are choosing customized and repeat wellness plans.
Strategic Response:Menopause programs by Ritual and Bonafide Health are monthly shipping menopause box subscription programs with educational apps. MenoLabs uses digital health integration wherein consumers can monitor symptoms and be directed products. Models like these have created higher customer interaction and brand loyalty in the long term, particularly on the side of digitally enabled 40+ consumers.
Clinical Support and Scientific Clarity
Shift:Increasingly, clients expect scientific proof of menopause supplements. In response to higher skepticism toward unproven "hormone-balancing" claims, these days’ companies have to provide evidence-based outcomes and transparency regarding ingredient performance and clinical trials.
Strategic Response:Brands such as Equelle and Bonafide are becoming clinically tested menopause supplement pioneers, entering human trials and releasing white papers. Estroven puts front and center the peer-reviewed science on its website, with Thorne and Pure Encapsulations adding third-party lab certification to build consumer confidence for health-conscious consumers.
Addition of Mood, Cognitive & Bone Health Support
Shift:Menopause supplements are transitioning from vasomotor symptoms to mood stability, brain fog, and bone health-a more holistic view of middle life health. Women are seeking one-stop health solutions to total physical and psychological well-being.
Strategic Response:Nature's Way and Garden of Life introduced multicomponent menopause products with adaptogens, calcium, vitamin D, magnesium, and B-complex blends for mental and emotional wellness. NaturesPlus introduced MenoEnergy with CoQ10 and ashwagandha to meet the needs of those consumers looking for not just symptomatic support but also energy support on a daily basis.
Menopause Awareness in Wellness and Media
Shift:Menopause cultural taboos are dissolving as wellness blogs and media sites more and more openly talk about middle age women's health. It has empowered consumers to look for better, and de-stigmatized supplement taking during hormone change times.
Strategic Response:Menopause brands Kindra and Womaness are leading the trend with aspirational branding and edutainment advertising. Gen X women influencer endorsement and podcast endorsement are gaining traction as endorsements, backed by sponsors. Such channels enable building communities and trust, which embarks upon such customer-brand relationships in a more genuine fashion.
Growing Demand in Asia-Pacific and Emerging Markets
Shift:While the USA and Europe continue to maintain dominance of the market, menopause support demand is gaining traction in South Korea, Japan, and India. Increased awareness, aging populations, and increased disposable incomes propel menopause health supplement use in emerging economies.
Strategic Response: Amor pacific and Japan's FANCL introduced function-based supplements that attracted midlife women with a traditional botanicals and digestive routine. Himalaya and Wellbeing Nutrition introduced Ayurveda-formulated menopausal mixes in India. Western players wish to collaborate with local distributors to target this under-penetrated but rapidly growing consumer segment.
Following is the tabular presentation of forecasted five-year growth rates for the top five markets. They are expected to register strong consumption until 2035.
Country | CAGR (2025 to 2035) |
---|---|
United States | 5.5% |
China | 6.5% |
India | 7.2% |
Germany | 4.8% |
United Kingdom | 4.6% |
The United States is the largest menopause supplements market due to increasing concern over women's health as well as sticky demand for clean-label, plant-based solutions. People are searching frantically for alternatives to hormone replacement therapies, and it has led to the mass consumption of herbal supplements such as black cohosh, red clover, and evening primrose oil. Increased web health sites are a primary reason for popularizing individualized nutrition so that women can control symptoms of hot flashes, night sweats, mood swings, and sleep disorders with tailored supplement regimens.
Product formats such as powders, liquid tonics, and gummies are being manufactured by businesses as a method to access consumers who are living increasingly busy lives and health concerns. Buying decisions also often follow word of mouth and advertising produced with backing from celebrities on-line.
The regulatory environment for food and nutrients is quite favourable to supplements, thus assuring high levels of new product launching. This setting and health-oriented population that is willing to undertake positive efforts towards taking care of their health is driving strong growth through retail as well as digital channels.
Traditional medicine and fast-changing nutraceutical industry on twin pillars where menopause supplement market is booming in China. Increasing numbers of Chinese women are consuming dietary supplements, not only to control symptoms, but also to boost vitality, complexion, and bone strength.
Classic Chinese herbs such as dong quai and ginseng are now complemented by newer functional foods such as collagen, soy isoflavones, and calcium. Shanghai and Beijing as luxury cities are hubs of luxury well-being services with web health platforms and powerhouses like Tmall and JD.com bridging low-urban areas to luxury wellness awareness and access.
Even a disease-stricken middle class now is relating menopause maintenance to wellness on the long-term and this is pressuring extensive supplementation, instead of the band-aid. Local businesses are making strategic alliances with research centers to determine the effectiveness of local ingredients, thereby further boosting customers' confidence.
The Indian menopause supplement market is coming under increasing acceptance, especially as word of the role of diet during mid-life in women spreads. Indian women, who are more western health trend-oriented and more urbanized, are thus turning towards natural products to help alleviate conditions such as hormonal imbalance, mood swings, and fatigue. Ayurvedic ingredients such as ashwagandha, shatavari, and amla are used most extensively in products which are developed after following Indian dietary consumption and lifestyle trends.
The emergence of direct-to-consumer (D2C) wellness and health companies has also supported this trend through customized packs of supplements, tele-consultation with well-being specialists, and subscription ease. With ancient doctors and contemporary nutritionists joining forces to integrate age-old knowledge with scientific proof, the legitimacy of customers further intensifies. Digital media ads, particularly women beyond their 40s, are triggering health seeking behavior in Tier 1 and Tier 2 cities.
Segment | Value Share (2025) |
---|---|
Nutritional Supplements (By Product Type) | 38.2% |
Given the continued shift towards natural, holistic modalities in addressing menopausal and perimenopausal symptomology, nutritional supplements are the most widely utilized categories of menopause supplement. The category includes many plant hormones, minerals, vitamins and herbal extracts, such as black cohosh, red clover, calcium, magnesium, soy isoflavones, vitamin D and omega-3s.
Ingredients address mental and body symptoms, like fatigue and insomnia, bone loss, mood swings, hot flashes. Dietary supplements have an advantageous risk profile and long-term use compared to other hormonal and non-hormonal drug therapy with a more positive experience among women who are not being or cannot afford HRT. The evidence on other HRT risks of breast cancer and blood clots, especially in the US, UK and Germany, support the practice.
Globally, menopause is reinvented by nutrition science as a positive experience of well-being rather than an adaptive medical condition. Labeling on products markets multi-component interventions to specific menopausal stages perimenopause, menopause, and postmenopause and hormone-free items with added phytoestrogens and stress-buffering plant nutrients ashwagandha and maca root.
Consumer confidence in natural ingredients drives growth. Application of clinically tested ingredients like S-equol, genistein, and standardized black cohosh extracts raises product profiles. Clean label ideas are also a part of the segment, forcing brands to drop artificial coloring, allergens, and synthetic fillers.
Segment | Value Share (2025) |
---|---|
Gummies (By Form) | 18.5% |
Gummies are becoming increasingly used in the menopause supplements space, specifically in young menopausal consumers (60-50 years) who are opting for easy-to-swallow, tasty, and convenient presentations compared to the traditional pill or capsules. Gummies have the biggest consumer acceptability among palatable, pill-free, and lifestyle-conformable perceived by the consumer and especially those with swallowing obstacles or sensitive to the supplement.
Gummies also have things to help with menopause, like vitamins B6, B12 and D3; magnesium; biotin; and botanicals such as evening primrose oil, red clover and chaste berry. They are typically blended to provide multi-symptom relief, relieving hot flashes as well as the sleep disturbance, mood disorder and dry skin that often accompany menopause.
The category is backed by strong crossover from the beauty-from-within and functional confectionery categories, enabling brands to develop menopause gummies that also support hair, skin, and nails, otherwise vulnerable during bouts of hormonal changes. Collagen peptides or hyaluronic acid are typically being utilized in current formats, migrating beauty benefit to wellbeing functionality.
Millennial and Gen X women are propelling gummy adoption, seeking adorable, Instagram-friendliness, sugar-free, plant-based gummies sold in eco-friendly packaging. The tone of these gummies is positive about the body and cheerful, destigmatizing menopause through inspiring stories as opposed to doctor jargon.
The menopause supplement market is experiencing high competition driven by rising awareness about women's health and greater interest in plant-based and clinically supported products. NOW Foods and Nature's Way are two of the firms that have gained the top position as market players by providing all-natural, hormone-free solutions for a range of symptoms experienced during menopause including hot flashes, mood swings, and bone diseases.
Segments. Companies are being segmented clearly by clean labeling, condition-specific formulation, and transparency. Clinically validated actives like black cohosh, red clover, and ashwagandha, and blends of vitamin D, calcium, and magnesium, have made such businesses capable of reacting to evolving consumer demand. Visibility is what fuels category demand and availability.
Due to online direct-to-consumer web sites and subscription services that provide menopause support supplements. Strategic rebranding in the form of acquisitions and rebranding, in addition to wellness education drives, are also fast building brand loyalties. Multinational pharma leaders are now penetrating the market leveraging their long-entrenched R&D base and medical goodwill while launching higher-grade nutraceutical alternatives.
For instance:
The global industry is estimated at a value of USD 983.4 million in 2025.
Sales increased at 5.2% CAGR between 2020 and 2024.
Some of the leaders in this industry include Holland & Barrett, Vitabiotics, Health & Her, Promensil, Flourish, Natures Garden, A. Vogel, DR. VEGAN, Schwabe Pharma, and Others.
The growth of the menopause supplement market is driven by rising awareness, a preference for natural remedies, an aging female population, increasing e-commerce access, and growing acceptance of menopause as a mainstream health topic.
The industry is projected to grow at a forecast CAGR of 5.7% from 2025 to 2035.
The market is segmented into Hormonal Supplements, Non-hormonal Supplements, Nutritional Supplements, and Others.
The industry is categorized based on form into Tablets, Capsules, Liquids, Powders, Gummies, and Soft Gels.
Sales are channeled through Store-based, Modern Trade, Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies.
Industry analysis has been carried out in key regions, including North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, Central Asia, Balkan and Baltic Countries, Russia and Belarus, and the Middle East & Africa.
Calcium Caseinate Market Analysis by End Use Application and Functionality Through 2025 to2035
Aquafeed Enzymes Market Analysis by Enzyme Type, Form, Aquatic Animal, and Region Through 2035
Cattle Nutrition Market Analysis by Cattle Type, Nutrition Type, Application, Life Stage Through 2025 to 2035
Calorie Supplements Market Analysis by Form, Packaging, Flavor, Sales Channel and Region Through 2025 to 2035
Chickpea Milk Market Analysis by Category, Flavor and End Use Through 2025 to 2035
Coconut Butter Market Analysis by End-use Application Sales Channel Through 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.